PARP-3 is a Mono-ADP-ribosylase That Activates PARP-1 in the Absence of DNA

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Jan 13

PMID 20064938

Citations 81

Authors

Olga Loseva

Ann-Sofie Jemth

Helen E Bryant

Herwig Schuler

Lari Lehtio

Tobias Karlberg

Thomas Helleday

Affiliations

Soon will be listed here.

Abstract

The PARP-3 protein is closely related to the PARP-1 and PARP-2 proteins, which are involved in DNA repair and genome maintenance. Here, we characterized the biochemical properties of human PARP-3. PARP-3 is able to ADP-ribosylate itself as well as histone H1, a previously unknown substrate for PARP-3. PARP-3 is not activated upon binding to DNA and is a mono-ADP-ribosylase, in contrast to PARP-1 and PARP-2. PARP-3 interacts with PARP-1 and activates PARP-1 in the absence of DNA, resulting in synthesis of polymers of ADP-ribose. The N-terminal WGR domain of PARP-3 is involved in this activation. The functional interaction between PARP-3 and PARP-1 suggests that it may have a role in DNA repair. However, here we report that PARP-3 small interfering RNA-depleted cells are not sensitive to the topoisomerase I poison camptothecin, inducing DNA single-strand breaks, and repair these lesions as efficiently as wild-type cells. Altogether, these results suggest that the interaction between PARP-1 and PARP-3 is unrelated to DNA single-strand break repair.

Citing Articles

PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma.

Li Y, Liu Y, Ma J, Yang Y, Yue Q, Zhu G Cell Death Discov. 2025; 11(1):35.

PMID: 39885134 PMC: 11782537. DOI: 10.1038/s41420-025-02296-0.

Mono-ADP-ribosylation, a MARylationmultifaced modification of protein, DNA and RNA: characterizations, functions and mechanisms.

Wu H, Lu A, Yuan J, Yu Y, Lv C, Lu J Cell Death Discov. 2024; 10(1):226.

PMID: 38734665 PMC: 11088682. DOI: 10.1038/s41420-024-01994-5.

Tankyrase-1 regulates RBP-mediated mRNA turnover to promote muscle fiber formation.

Mubaid S, Sanchez B, Algehani R, Skopenkova V, Adjibade P, Hall D Nucleic Acids Res. 2024; 52(7):4002-4020.

PMID: 38321934 PMC: 11040007. DOI: 10.1093/nar/gkae059.

Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP.

Frigon L, Pascal J Nucleic Acids Res. 2023; 51(22):12492-12507.

PMID: 37971310 PMC: 10711553. DOI: 10.1093/nar/gkad1064.

ADP-ribosylation from molecular mechanisms to therapeutic implications.

Suskiewicz M, Prokhorova E, Rack J, Ahel I Cell. 2023; 186(21):4475-4495.

PMID: 37832523 PMC: 10789625. DOI: 10.1016/j.cell.2023.08.030.

References

Tao Z, Gao P, Hoffman D, Liu H . Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif. Biochemistry. 2008; 47(21):5804-13. DOI: 10.1021/bi800018a. View

Jones P, Altamura S, Boueres J, Ferrigno F, Fonsi M, Giomini C . Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem. 2009; 52(22):7170-85. DOI: 10.1021/jm901188v. View

Altmeyer M, Messner S, Hassa P, Fey M, Hottiger M . Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites. Nucleic Acids Res. 2009; 37(11):3723-38. PMC: 2699514. DOI: 10.1093/nar/gkp229. View

Hassa P, Hottiger M . The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci. 2007; 13:3046-82. DOI: 10.2741/2909. View

Kleine H, Poreba E, Lesniewicz K, Hassa P, Hottiger M, Litchfield D . Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol Cell. 2008; 32(1):57-69. DOI: 10.1016/j.molcel.2008.08.009. View

Hassa P, Haenni S, Elser M, Hottiger M . Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?. Microbiol Mol Biol Rev. 2006; 70(3):789-829. PMC: 1594587. DOI: 10.1128/MMBR.00040-05. View

Ruf A, Mennissier de Murcia J, de Murcia G, Schulz G . Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken. Proc Natl Acad Sci U S A. 1996; 93(15):7481-5. PMC: 38770. DOI: 10.1073/pnas.93.15.7481. View

Smith L, Willmore E, Austin C, Curtin N . The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks. Clin Cancer Res. 2005; 11(23):8449-57. DOI: 10.1158/1078-0432.CCR-05-1224. View

Schreiber V, Dantzer F, Ame J, de Murcia G . Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol. 2006; 7(7):517-28. DOI: 10.1038/nrm1963. View

10.

Hakme A, Wong H, Dantzer F, Schreiber V . The expanding field of poly(ADP-ribosyl)ation reactions. 'Protein Modifications: Beyond the Usual Suspects' Review Series. EMBO Rep. 2008; 9(11):1094-100. PMC: 2581850. DOI: 10.1038/embor.2008.191. View

11.

Ewing R, Chu P, Elisma F, Li H, Taylor P, Climie S . Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol. 2007; 3:89. PMC: 1847948. DOI: 10.1038/msb4100134. View

12.

Loesberg C, Van Rooij H, Smets L . Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation). Biochim Biophys Acta. 1990; 1037(1):92-9. DOI: 10.1016/0167-4838(90)90106-p. View

13.

Bryant H, Petermann E, Schultz N, Jemth A, Loseva O, Issaeva N . PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination. EMBO J. 2009; 28(17):2601-15. PMC: 2738702. DOI: 10.1038/emboj.2009.206. View

14.

Oliver A, Ame J, Roe S, Good V, de Murcia G, Pearl L . Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2. Nucleic Acids Res. 2004; 32(2):456-64. PMC: 373339. DOI: 10.1093/nar/gkh215. View

15.

Tao Z, Gao P, Liu H . Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications. J Am Chem Soc. 2009; 131(40):14258-60. DOI: 10.1021/ja906135d. View

16.

Sallmann F, Vodenicharov M, Wang Z, Poirier G . Characterization of sPARP-1. An alternative product of PARP-1 gene with poly(ADP-ribose) polymerase activity independent of DNA strand breaks. J Biol Chem. 2000; 275(20):15504-11. DOI: 10.1074/jbc.275.20.15504. View

17.

Farmer H, McCabe N, Lord C, Tutt A, Johnson D, Richardson T . Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005; 434(7035):917-21. DOI: 10.1038/nature03445. View

18.

Ogata N, Ueda K, HAYAISHI O . ADP-ribosylation of histone H2B. Identification of glutamic acid residue 2 as the modification site. J Biol Chem. 1980; 255(16):7610-5. View

19.

Lehtio L, Jemth A, Collins R, Loseva O, Johansson A, Markova N . Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3. J Med Chem. 2009; 52(9):3108-11. DOI: 10.1021/jm900052j. View

20.

Rouleau M, El-Alfy M, Levesque M, Poirier G . Assessment of PARP-3 distribution in tissues of cynomolgous monkeys. J Histochem Cytochem. 2009; 57(7):675-85. PMC: 2699323. DOI: 10.1369/jhc.2009.953380. View